These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19669304)

  • 1. A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).
    Lee YM; Sutedja DS; Wai CT; Dan YY; Aung MO; Zhou L; Cheng CL; Wee A; Lim SG
    Hepatol Int; 2008 Jun; 2(2):196-201. PubMed ID: 19669304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.
    Sharma BC; Kumar A; Garg V; Reddy RS; Sakhuja P; Sarin SK
    J Clin Exp Hepatol; 2012 Dec; 2(4):333-7. PubMed ID: 25755455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
    Van Wagner LB; Koppe SW; Brunt EM; Gottstein J; Gardikiotes K; Green RM; Rinella ME
    Ann Hepatol; 2011; 10(3):277-86. PubMed ID: 21677329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran.
    Baniasadi N; Salajegheh F; Pardakhty A; Seyedmirzaee SM; Hayatbakhsh MM; Nikpoor AR; Mohammadi M
    Hepat Mon; 2015 Nov; 15(11):e32418. PubMed ID: 26834792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet.
    Yalniz M; Bahçecioğlu IH; Kuzu N; Celebi S; Ataseven H; Ustündağ B; Ozercan IH; Sahin K
    Dig Dis Sci; 2007 Sep; 52(9):2380-6. PubMed ID: 17415655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
    Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
    Kedarisetty CK; Bhardwaj A; Kumar G; Rastogi A; Bihari C; Kumar M; Sarin SK
    Indian J Gastroenterol; 2021 Feb; 40(1):41-49. PubMed ID: 33772456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
    Adams LA; Zein CO; Angulo P; Lindor KD
    Am J Gastroenterol; 2004 Dec; 99(12):2365-8. PubMed ID: 15571584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis.
    Yalcin M; Akarsu M; Celik A; Sagol O; Tunali S; Ertener O; Bengi G; Akpinar H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():167-75. PubMed ID: 25910299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis.
    Duman DG; Ozdemir F; Birben E; Keskin O; Ekşioğlu-Demiralp E; Celikel C; Kalayci O; Kalayci C
    Dig Dis Sci; 2007 Oct; 52(10):2520-4. PubMed ID: 17436095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
    Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
    Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.
    Zein CO; Yerian LM; Gogate P; Lopez R; Kirwan JP; Feldstein AE; McCullough AJ
    Hepatology; 2011 Nov; 54(5):1610-9. PubMed ID: 21748765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.
    Shenoy KT; Balakumaran LK; Mathew P; Prasad M; Prabhakar B; Sood A; Singh SP; Rao NP; Zargar SA; Bignamini AA
    J Clin Exp Hepatol; 2014 Jun; 4(2):94-100. PubMed ID: 25755546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
    Harrison SA; Ruane PJ; Freilich B; Neff G; Patil R; Behling C; Hu C; Shringarpure R; de Temple B; Fong E; Tillman EJ; Rolph T; Cheng A; Yale K
    JHEP Rep; 2023 Jan; 5(1):100563. PubMed ID: 36644237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.
    Shavakhi A; Minakari M; Firouzian H; Assali R; Hekmatdoost A; Ferns G
    Int J Prev Med; 2013 May; 4(5):531-7. PubMed ID: 23930163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.